Sir Cliff Richard has issued a plea to King Charles III after revealing he has been treated for prostate cancer for the past ...

The 85-year-old singer has revealed the disease was caught early during insurance health checks and is now backing calls for national screening ...

Sir Cliff Richard has revealed he was diagnosed with prostate cancer after it was picked up by doctors during a check-up ...

The Vince Lombardi Cancer Foundation shared some good news on Wisconsin’s Midday News, announcing more than $300,000 in grant funding for cancer research ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Radiopharm Theranostics Limited (NASDAQ:RADX) is a biotechnology company developing treatments for ailments such as brain ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology company developing treatments for ailments such as prostate and ...

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...

Medicare and Medicaid dual eligibility, higher comorbidity burden, and preexisting anxiety independently tied to greater risk.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...